The drug Glybera, a treatment for a rare genetic disease which will cost more than €1m per patient, will be the most expensive medicine on the planet

Approval of aid to Spanish banks comes as bond yields rise above 7.1 per cent and finance minister downgrades GDP forecast for 2013

Investors should be pleased that the multinational demonstrated pricing discipline in the face of an escalating bidding war